PharmiWeb.com - Global Pharma News & Resources

Medical comms - Press Releases

Date Title Company
25-Mar-2024 Gedeon Richter Selects Trial Interactive for Clinical Trial Management TransPerfect Life Sciences
25-Mar-2024 Landmark NHS deal gives patients access to groundbreaking light-activated antimicrobial to combat antimicrobial resistance Mid Yorkshire Teaching NHS Trust
25-Mar-2024 NEW UK QUALITATIVE STUDY IDENTIFIES MEN EXPERIENCE BARRIERS TO DIAGNOSIS AND TREATMENT OF TESTOSTERONE DEFICIENCY AT EVERY LEVEL OF THE CARE PATHWAY Besins Healthcare UK
25-Mar-2024 Birmingham scientists using novel hydrogel to create ‘lollipops’ for mouth cancer diagnostic University of Birmingham
22-Mar-2024 Research reveals link between menstrual cycles, emotions, and sleep patterns in women University of East Anglia
20-Mar-2024 Bayer and Thermo Fisher Scientific collaborate to increase patient access to precision cancer medicines Bayer AG and Thermo Fisher Scientific Inc
20-Mar-2024 Pharma sector backs Labour on R&D, research reveals Ayming UK
20-Mar-2024 Canon Medical introduces new CT system, Aquilion Serve SP to UK market to ease workload pressure on healthcare professionals Canon Medical Systems LTD
20-Mar-2024 Aston University partnership with medicine manufacturer improves oral medicine formulation development process Aston University
20-Mar-2024 LogiPharma Launches Annual Playbook Featuring Big Pharma Data and Insights LogiPharma
14-Mar-2024 Anocca AB Licenses Gene Editing Technology from EmendoBio Inc. Anocca AB
14-Mar-2024 PROTEONIC ANNOUNCES PARTNERSHIP WITH GINKGO BIOWORKS AND JOINS THE GINKGO TECHNOLOGY NETWORK Ginkgo Bioworks
13-Mar-2024 LogiPharma Delivers Diversity, Equity, and Inclusion as a Key Theme for 2024 LogiPharma
12-Mar-2024 medac unveils new Global Corporate Brand medac group
11-Mar-2024 OncoZenge Explores Strategic Options for BupiZenge™ in China OncoZenge
08-Mar-2024 Johnson & Johnson submits application to the European Medicines Agency for DARZALEX® (daratumumab)-based quadruplet therapy for the treatment of patients with transplant-eligible, newly diagnosed multiple myeloma Johnson & Johnson
08-Mar-2024 Johnson & Johnson submits application to the European Medicines Agency for DARZALEX® (daratumumab)-based quadruplet therapy for the treatment of patients with transplant-eligible, newly diagnosed multiple myeloma Johnson & Johnson
08-Mar-2024 Curium Announces First Commercial Doses in Italy of PYLCLARI® – An Innovative 18F-PSMA PET Tracer Indicated in Patients With Prostate Cancer Curium
06-Mar-2024 Semantic Data 2024: Taxonomy, Ontology and, Knowledge Graphs - First Speakers Announced Henry Stewart Events
06-Mar-2024 ACI Group partners with Alvinesa® Natural Ingredients to distribute its sustainable product portfolio into the UK market ACI Group